Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Soren Olson

Orthopaedic Surgery Spokane, WA Medical Doctor

NPI 1285646265 CMS profile 103925

601 W 5Th Ave Ste 400, Spokane, WA 99204

Open in the dashboard

General payments

$10,495

51 records reported · program years 2019–2024

Research payments

$0

Paid to them · None reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Soren Olson of Spokane, WA is reported in the CMS Open Payments database as having received $10,495 across 51 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 70th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $189 2
2023 General $982 1
2022 General $138 4
2021 General $350 17
2020 General $7,626 15
2019 General $1,210 12

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Soren Olson
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Soren Olson were reported at $0. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Soren Olson Orthopaedic Surgery median Middle half National median
2019 $1,210 $644 $140–$2,844 $163
2020 $7,626 $312 $75–$1,860 $114
2021 $350 $520 $117–$2,495 $132
2022 $138 $598 $128–$2,731 $149
2023 $982 $461 $128–$2,264 $160
2024 $189 $497 $134–$2,475 $164
2025 $0 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Arthrex, Inc. $9,008 38 payments
  2. Summit Surgical Corp. $1,060 2 payments
  3. DePuy Synthes Sales Inc. $296 7 payments
  4. Pacira Pharmaceuticals Incorporated $49 1 payment
  5. Vericel Corporation $43 2 payments
  6. Sawtooth Surgical Solutions Inc $39 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $6,000 1 payment
  2. Travel and Lodging $2,107 13 payments
  3. Food and Beverage $1,609 34 payments
  4. Education $779 3 payments
Products named General payments · program years 2019–2024
  1. DISTAL EXTREMITIES IMPLANTS HINDFOOT & ANKLE ANKLE FUSION $96 2 payments
  2. Velys Ortho-Hip $84 1 payment
  3. ACTIS $84 1 payment
  4. Velys Ortho-Knee $84 1 payment
  5. ATTUNE $84 1 payment
  6. DISTAL EXTREMITIES IMPLANTS SCREWS METAL COMPRESSION SCREWS $78 1 payment
  7. TFN ADVANCED $75 1 payment
  8. ARTHROPLASTY IMPLANTS REVERS TOTAL SHOULDER REVERS $72 1 payment
  9. EX NAILS $66 2 payments
  10. DISTAL EXTREMITIES IMPLANTS FRACTURE MANAGEMENT MINI FRAGMENT $49 1 payment
  11. Other $235 8 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 9 drugs

Part D claims

279

Median for Sports Medicine: 144

Drug cost

$1,988

Median for Sports Medicine: $1,027

Branded share of claims

26.2%

Median for Sports Medicine: 0%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 58 $829
Oxycodone Hcl Generic 32 $262
Celecoxib Generic 12 $223
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 15 $192
Amoxicillin Generic 74 $155
Meloxicam Generic 33 $146
Ondansetron Hcl Generic 21 $77
Clindamycin Hcl Generic 19 $69
Cephalexin Generic 15 $34

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,691 Part D prescribers listed as Sports Medicine; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 59 billing codes

Paid by Medicare

$116,251

Of which drugs: $7,931

Medicare patients

260

Average age 74

Services billed

7,767

144 women, 116 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 63%
Diabetes 23%
Depression 22%
Ischemic heart disease 19%
Osteoporosis 17%
Atrial fibrillation 15%
Chronic kidney disease 15%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, methylprednisolone acetate, 1 mg J1010 Office 55 6,060 $601
Injection, methylprednisolone acetate, 80 mg J1040 Office 26 28 $163

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

51 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Washington

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record